Q1 2019 Holdings
Filed 2019-05-15 | 18 holdings | $127.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $23.6K | 210,937 | 18.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $18.1K | 446,905 | 14.2% |
| Odonate Therapeutics Inc | COM | 676079106 | $13.2K | 595,850 | 10.4% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $13.0K | 383,480 | 10.2% |
| Sutro BioPharma Inc | COM | 869367102 | $12.8K | 1,125,579 | 10.1% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $11.5K | 532,920 | 9.1% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $9.7K | 1,059,938 | 7.6% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $7.3K | 639,290 | 5.7% |
| Sunesis Pharmaceuticals Inc | COM | 867328700 | $4.6K | 3,750,000 | 3.6% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.4K | 118,500 | 2.7% |
| Aravive Inc(VSAREUR) | COM | 03890D108 | $3.1K | 442,733 | 2.4% |
| Catabasis Pharmaceuticals Inc(CATBEUR) | COM | 14875P206 | $2.4K | 300,000 | 1.9% |
| Evelo Biosciences Inc | COM | 299734103 | $1.8K | 227,529 | 1.4% |
| Urovant Sciences Ltd | COM | G9381B108 | $1.6K | 157,480 | 1.2% |
| Millendo Therapeutics Inc | COM | 60040X103 | $677 | 45,101 | 0.5% |
| Surface Oncology Inc | COM | 86877M209 | $373 | 78,300 | 0.3% |
| PDS Biotechnology Corp(PDSB) | COM | 70465T107 | $68 | 9,166 | 0.1% |
| Trillium Therapeutics Inc | COM | 89620X506 | $47 | 71,619 | 0.0% |